Chiusura precedente | 17,36 |
Aperto | 16,59 |
Denaro | 0,00 x 0 |
Lettera | 0,00 x 0 |
Min-Max giorno | 16,59 - 16,59 |
Intervallo di 52 settimane | 10,40 - 16,59 |
Volume | |
Media Volume | 0 |
Capitalizzazione | N/D |
Beta (5 anni mensile) | N/D |
Rapporto PE (ttm) | N/D |
EPS (ttm) | N/D |
Prossima data utili | N/D |
Rendimento e dividendo (forward) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | N/D |
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Independent investigation concluded – Full Year 2020 (restated) and 2021 auditedFourth Quarter 2021: Sales from continuing operations grew by 23 % in local currency to CHF 1.242 billion driven by strong pricing and volume expansionFourth Quarter 2021: EBITDA margin increased to 16.3 % from 16.1 % supported by operating leverage and continued higher pricing, which diminished ongoing raw material, energy, and logistics cost inflationFull Year 2021: Sales
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR MUTTENZ, MAY 17, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today announced that it has scheduled its Annual General Meeting (AGM) for 24 June 2022, and that with the closing of the AGM the Governance Agreement between Clariant and SABIC will expire. Both parties entered into the agreement on 17 September 2018 when SABIC became Clariant’s anchor shareholder (see 2018 Media Release: Clariant and SABIC enter Governan
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Restatement of 2020 financial statements required, implying a continuing operations EBITDA margin of 15.5 % (preliminary, unaudited) vs. 15.0 % previously reported2021 continuing operations EBITDA margin of 16.2 % (preliminary, unaudited) in line with previous guidance No impact on sales, cash and cash equivalents previously reported in 2020 and 2021Clariant to present its audited Full Year 2021 and restated 2020 results by latest 30 May 2022SIX Exchang